2.7868

2.01% 0.0568

Perspective Therapeutics Inc (CATX)

Overview News Price History Discussions Forecast Stock Split

Perspective Therapeutics Inc stock is traded at $2.7868, with a volume of 48,171. It is up +2.01% in the last 24 hours and up +16.04% over the past month. Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.

Previous Close:

$2.73

Open:

$2.7

24h Volume:

48,171

Relative Volume:

0.03

Market Cap:

$206.66M

Revenue:

$6.96M

Net Income/Loss:

$-46.51M

P/E Ratio:

-16.24

EPS:

-0.1716

Net Cash Flow:

$-37.99M

1W Performance:

+1.64%

1M Performance:

+16.04%

6M Performance:

-24.32%

1Y Performance:

-21.10%

1-Day Range:

$2.69

$2.785

1-Week Range:

$2.645

$2.82

52-Week Range:

$1.60

$5.3881

Perspective Therapeutics Inc Stock (CATX) Company Profile

Name

Perspective Therapeutics Inc

Sector

Healthcare (1119)

Industry

Medical Devices (144)

Phone

509-375-1202

Address

350 Hills Street, Suite 106, Richland

Employee

Twitter

Next Earnings Date

2025-08-08

Latest SEC Filings

CATX's Discussions on Twitter

Compare CATX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CATX Perspective Therapeutics Inc	2.78	202.94M	6.96M	-46.51M	-37.99M	-0.1716
ABT Abbott Laboratories	128.32	219.88B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	96.31	141.54B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	355.39	133.39B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	99.47	124.82B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	85.58	48.84B	5.88B	1.34B	799.60M	2.3489

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-24-25	Resumed	Truist	Buy
Oct-10-25	Initiated	BTIG Research	Buy
Mar-13-25	Initiated	H.C. Wainwright	Buy
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Nov-25-24	Downgrade	BofA Securities	Buy → Neutral
Oct-24-24	Initiated	UBS	Buy
Oct-01-24	Initiated	Wedbush	Outperform
Sep-25-24	Initiated	Truist	Buy
Jul-25-24	Initiated	BofA Securities	Buy
May-09-24	Initiated	Cantor Fitzgerald	Overweight

View All

Perspective Therapeutics Inc Stock (CATX) Latest News

Jan 04, 2026

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Jan 04, 2026

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jan 04, 2026

Jan 01, 2026

Why Perspective Therapeutics Inc. stock remains a top recommendationFederal Reserve Announcements & Investor Community Interactions - bollywoodhelpline.com

Jan 01, 2026

Perspective Therapeutics (NYSEAMERICAN:CATX) Trading Up 0.4%Should You Buy? - MarketBeat

Jan 01, 2026

Dec 31, 2025

Market Review: Will Perspective Therapeutics Inc stock continue upward momentumTrend Reversal & Risk Adjusted Buy and Sell Alerts - moha.gov.vn

Dec 31, 2025

Dec 26, 2025

Perspective Therapeutics (FRA:AAJ0) EV-to-OCF : -0.36 (As of Dec. 26, 2025) - GuruFocus

Dec 26, 2025

Aug Decliners: How Perspective Therapeutics Inc AAJ0 stock benefits from digital adoption2025 Stock Rankings & Daily Stock Trend Watchlist - moha.gov.vn

Dec 26, 2025

Dec 23, 2025

Perspective Therapeutics Inc Stock Analysis and ForecastRisk Management Strategies & Affordable Portfolio Tips - earlytimes.in

Dec 23, 2025

Dec 20, 2025

Can Perspective Therapeutics Inc. stock resist market sell offsWeekly Investment Recap & Weekly Momentum Picks - Улправда

Dec 20, 2025

Aug EndMonth: What market sentiment indicators show for Perspective Therapeutics Inc. (AAJ0) stockWeekly Profit Recap & Proven Capital Preservation Methods - Улправда

Dec 20, 2025

Perspective Therapeutics Earnings Notes - Trefis

Dec 20, 2025

Published on: 2025-12-20 10:25:50 - Улправда

Dec 20, 2025

Dec 19, 2025

How Perspective Therapeutics Inc. stock valuations compare to rivalsMarket Trend Review & Weekly Watchlist for Consistent Profits - Улправда

Dec 19, 2025

Published on: 2025-12-20 05:01:39 - Улправда

Dec 19, 2025

Market Review: What market sentiment indicators show for Perspective Therapeutics Inc. (AAJ0) stockQuarterly Growth Report & Low Risk High Win Rate Stock Picks - Улправда

Dec 19, 2025

Trading Recap: How Perspective Therapeutics Inc. stock valuations compare to rivals2025 Support & Resistance & AI Powered Market Trend Analysis - Улправда

Dec 19, 2025

Is Perspective Therapeutics Inc. stock in correction or buying zone2025 Fundamental Recap & Growth Focused Stock Reports - DonanımHaber

Dec 19, 2025

How Perspective Therapeutics Inc. (AAJ0) stock benefits from digital adoptionInsider Selling & Precise Trade Entry Recommendations - DonanımHaber

Dec 19, 2025

How Perspective Therapeutics Inc. stock compares to market leadersEarnings Growth Report & Community Supported Trade Ideas - DonanımHaber

Dec 19, 2025

Should I buy Perspective Therapeutics Inc. stock before earnings seasonJuly 2025 Spike Watch & Smart Investment Allocation Insights - Улправда

Dec 19, 2025

Will Perspective Therapeutics Inc. stock continue upward momentumGDP Growth & Safe Swing Trade Setups - Bölüm Sonu Canavarı

Dec 19, 2025

Dec 18, 2025

Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com

Dec 18, 2025

Dec 12, 2025